Daniel F. Hayes
0000-0003-3620-7575
Publication & Citation Trends
Publications
0 total
A temporary indwelling intravascular aphaeretic system for in vivo enrichment of circulating tumor cells OA
Cited by 109
Semantic Scholar
Discovery of ERD-308 as a Highly Potent Proteolysis Targeting Chimera (PROTAC) Degrader of Estrogen Receptor (ER). OA
Cited by 211
Semantic Scholar
Integrative Clinical Genomics of Metastatic Cancer OA
Cited by 750
Semantic Scholar
Comparison of HER2 status by fluorescence in situ hybridization and immunohistochemistry to predict benefit from dose escalation of adjuvant doxorubicin-based therapy in node-positive breast cancer patients. OA
Cited by 111
Semantic Scholar
CLIC4/mtCLIC, a p53-Regulated Organellar Chloride Channel Protein, Translocates to the Nucleus Following Apoptotic Stimuli and Alters Nuclear Chloride Content and pH
Cited by 0
Semantic Scholar
Circulating HER-2/erbB-2/c-neu (HER-2) extracellular domain as a prognostic factor in patients with metastatic breast cancer: Cancer and Leukemia Group B Study 8662.
Cited by 114
Semantic Scholar
Vascular endothelial growth factor and basic fibroblast growth factor urine levels as predictors of outcome in hormone-refractory prostate cancer patients: a cancer and leukemia group B study.
Cited by 157
Semantic Scholar
Association of angiogenesis in lymph node metastases with outcome of breast cancer. OA
Cited by 79
Semantic Scholar
Research Topics
Breast Cancer Treatment Studies
(235)
HER2/EGFR in Cancer Research
(166)
Cancer Genomics and Diagnostics
(158)
Estrogen and related hormone effects
(144)
Cancer Treatment and Pharmacology
(136)
Affiliations
Intermountain Healthcare
University of Vermont
Atrium Health Wake Forest Baptist
Cedars-Sinai Medical Center
Indiana University Health